Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Melanoma 20Lymphoma, T-Cell, Cutaneous 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Non-Hodgkin 13Lymphoma, Mantle-Cell 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Large-Cell, Immunoblastic 12Lymphoma 12Burkitt Lymphoma 12Lymphoma, Large-Cell, Anaplastic 11Leukemia, Myeloid, Acute 11Hodgkin Disease 11Congenital Abnormalities 11Uveal Melanoma 9Sezary Syndrome 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Mycosis Fungoides 9Multiple Myeloma 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Accelerated Phase 9Leukemia 9Immunoblastic Lymphadenopathy 9Waldenstrom Macroglobulinemia 8Recurrence 8Primary Myelofibrosis 8Myeloproliferative Disorders 8Myelodysplastic Syndromes 8

Interventions

pembrolizumab 3Nivolumab 2tislelizumab 1spartalizumab 1obinutuzumab 1naptumomab estafenatox 1durvalumab 1Rosiglitazone 1Metformin 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Melphalan × Dermatologic × Clear all
NCT00096083 2013-10-23

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Delcath Systems Inc.

Phase 2 Completed
56 enrolled
DermatologicEndocrineGastrointestinal

Adenocarcinoma Of Esophagus, Uveal Melanoma, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Melanoma, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Rectal Neoplasms, Somatostatinoma, Stomach Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡